The study, which included 183 breast cancer patients and 122 healthy individuals,
demonstrated effectiveness with an AUC of 0.832
,
as verified by the Ministry of Food and Drug Safety in South Korea.
MASTOCHECK measures quantitative values of three types of proteins in the blood using a mass spectrometer (LC-MS/MS)
and concludes a result combining the figure with a unique algorithm.
Analyzing the combination of three protein biomarkers associated with breast cancers
facilitates to screening breast cancer with a high accuracy.
MASTOCHECK is an in vitro diagnostic medical device designed for breast cancer screening.
In case the test results indicate a high-risk category,
it is recommended to consult with a medical specialist and undergo further confirmatory tests.
This product is a medical device. Please read and follow the precautions and instructions for use carefully.
The test results using this product alone cannot determine the diagnosis and treatment methods for stages 0, 1, and 2 of breast cancer.
For the diagnosis of stage 3 and 4 of breast cancer, additional clinical diagnostic tests are required.
